These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21156821)

  • 1. Angiotensin II type 1 receptor blocker inhibits arterial calcification in a pre-clinical model.
    Armstrong ZB; Boughner DR; Drangova M; Rogers KA
    Cardiovasc Res; 2011 Apr; 90(1):165-70. PubMed ID: 21156821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats.
    Neven E; Persy V; Dauwe S; De Schutter T; De Broe ME; D'Haese PC
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1741-50. PubMed ID: 20522801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
    Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
    Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of olmesartan on aortic intimal thickening after balloon injury through Apelin/APJ.
    Li Y; Guo J; Yu H; Zhou J; Chu X; Hou B; Ge J; Li T; Duan S; Xu H; Yang X
    Cardiovasc Pathol; 2020; 49():107230. PubMed ID: 32585603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pravastatin and olmesartan synergistically ameliorate renal failure-induced vascular calcification.
    Iijima K; Ito Y; Son BK; Akishita M; Ouchi Y
    J Atheroscler Thromb; 2014; 21(9):917-29. PubMed ID: 24834982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits.
    Arishiro K; Hoshiga M; Negoro N; Jin D; Takai S; Miyazaki M; Ishihara T; Hanafusa T
    J Am Coll Cardiol; 2007 Apr; 49(13):1482-9. PubMed ID: 17397679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic modulation of vascular smooth muscle cells during medial arterial calcification: a role for endothelin?
    Essalihi R; Ouellette V; Dao HH; McKee MD; Moreau P
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S147-50. PubMed ID: 15838266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
    Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
    J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
    Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in renal vessels following the long-term administration of an angiotensin II receptor blocker in Zucker fatty rats.
    Nakanishi K; Nagai Y; Honglan Piao ; Akimoto T; Kato H; Yanakieva-Georgieva N; Ishikawa Y; Yoshihara K; Ito K; Yamanaka N; Oite T
    J Renin Angiotensin Aldosterone Syst; 2011 Jun; 12(2):65-74. PubMed ID: 21385769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress.
    Tsuda M; Iwai M; Li JM; Li HS; Min LJ; Ide A; Okumura M; Suzuki J; Mogi M; Suzuki H; Horiuchi M
    Hypertension; 2005 Apr; 45(4):545-51. PubMed ID: 15723967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-Related Receptor γ Plays a Key Role in Vascular Calcification Through the Upregulation of BMP2 Expression.
    Kim JH; Choi YK; Do JY; Choi YK; Ha CM; Lee SJ; Jeon JH; Lee WK; Choi HS; Park KG; Lee IK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2384-90. PubMed ID: 26404484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cells.
    Ohtani K; Egashira K; Ihara Y; Nakano K; Funakoshi K; Zhao G; Sata M; Sunagawa K
    Hypertension; 2006 Oct; 48(4):664-70. PubMed ID: 16940231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
    Hayashi N; Yamamoto K; Ohishi M; Tatara Y; Takeya Y; Shiota A; Oguro R; Iwamoto Y; Takeda M; Rakugi H
    Hypertens Res; 2010 Nov; 33(11):1182-5. PubMed ID: 20703229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan.
    Jinno T; Iwai M; Li Z; Li JM; Liu HW; Cui TX; Rakugi H; Ogihara T; Horiuchi M
    Hypertension; 2004 Feb; 43(2):263-9. PubMed ID: 14707152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of losartan suppressing vascular calcification in rat aortic artery].
    Shao J; Wu P; Wu J; Li M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1060-4. PubMed ID: 27412937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease.
    Yamada S; Taniguchi M; Tokumoto M; Toyonaga J; Fujisaki K; Suehiro T; Noguchi H; Iida M; Tsuruya K; Kitazono T
    J Bone Miner Res; 2012 Feb; 27(2):474-85. PubMed ID: 21987400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells.
    Yamada T; Kondo T; Numaguchi Y; Tsuzuki M; Matsubara T; Manabe I; Sata M; Nagai R; Murohara T
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2363-9. PubMed ID: 17717297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic protective effects of a statin and an angiotensin receptor blocker for initiation and progression of atherosclerosis.
    Lee SG; Lee SJ; Thuy NVP; Kim JS; Lee JJ; Lee OH; Kim CK; Oh J; Park S; Lee OH; Kim SH; Park S; Lee SH; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y
    PLoS One; 2019; 14(5):e0215604. PubMed ID: 31050669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.